Detalles de la búsqueda
1.
Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance.
Diabetes Obes Metab
; 17(11): 1033-41, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26094974
2.
A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus.
Int J Clin Pract
; 69(6): 626-31, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25652751
3.
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial study.
Diabetes Obes Metab
; 16(3): 223-30, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23909985
4.
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
Diabetes Obes Metab
; 15(12): 1101-10, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23782502
5.
Effect of initial combination therapy with sitagliptin and metformin on ß-cell function in patients with type 2 diabetes.
Diabetes Obes Metab
; 14(1): 67-76, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22050786
6.
Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
Diabetes Obes Metab
; 14(12): 1123-8, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22831166
7.
Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study.
Diabetes Obes Metab
; 14(8): 745-52, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22405352
8.
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes.
Diabetes Obes Metab
; 14(5): 409-18, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22059736
9.
The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus.
Diabetes Obes Metab
; 13(7): 644-52, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21410627
10.
Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial.
Diabetes Obes Metab
; 13(2): 160-8, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21199268
11.
A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents.
Diabetes Obes Metab
; 13(9): 841-9, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21535346
12.
Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes.
Int J Clin Pract
; 65(9): 930-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849007
13.
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes.
Diabetes Obes Metab
; 12(5): 442-51, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20415693
14.
Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes.
Diabetes Obes Metab
; 12(3): 252-61, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20070351
15.
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
Int J Clin Pract
; 64(7): 984-90, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20412332
16.
Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans.
Science
; 259(5101): 1619-22, 1993 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-8456285
17.
Primary objective of study of sitagliptin in patients with ESRD on dialysis.
Am J Kidney Dis
; 62(3): 642, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23972060
18.
Initial treatment with fixed-dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes.
Diabetes Obes Metab
; 10(8): 626-37, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17645558
19.
Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.
Int J Clin Pract
; 62(8): 1279-84, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18705823
20.
Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function.
Int J Clin Pract
; 62(7): 1087-95, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18489578